July 1, 2026 · Form 4 insider transaction
Trieu Vuong bought 240,000 shares of Oncotelic Therapeutics, Inc. at $0.04 per share, a transaction worth $10.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
On July 1, 2026, Dr. Vuong Trieu purchased 240,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0431.